Third-quarter 2010 IBO Life Science Index sales grew 7.2%, 8.5% excluding currency, to $2,944.55 million. Operating profit improved 11.5% to $636.50 million, and operating margin gained 110 basis points to 22.5% of sales. Third-quarter revenue for Beckman Coulter’s Life Sciences segment declined 5.1%, 4.1% at constant currency, to $106.1 million to account for 12% of […]

South San Francisco, CA 12/3/10; Washington, DC 12/3/10—Fluidigm has filed an S-1 registration statement with the SEC for an IPO. Fluidigm provides microfluidic instrumentation and consumables for life science research, including gene expression, genotyping and digital PCR (see page 12). The number of shares and price range has not yet been determined. In 2009, the […]

Hopkinton and Woburn, MA 12/9/10—Life science instrument provider Caliper Life Sciences has agreed to acquire Cambridge Research & Instrumentation (CRi) for $20.0 million. CRi develops and markets preclinical and tissue-based multiplexed analysis systems. The company is expected to have 2010 revenues of $12.0 million. Caliper stated that the technology should deliver a growth rate of […]

New York, NY 12/9/10—Citing three people familiar with the matter, Bloomberg reported on December 9 that Beckman Coulter is considering a sale of the company or going private and has hired Goldman Sachs Group to study the matter. Possible buyers include private equity groups, industrial conglomerates or diagnostics companies. A decision is not expected for […]

Despite drastic reductions in pharmaceutical R&D headcount and spending, which have reduced growth, flash chromatography, a preparative LC technique, accounted for more than $100 million in annual revenues in 2009 (see table, page 6) and is expected to grow in the mid-to-high single digits. Demand for flash chromatography comes mainly from the pharmaceutical, biotechnology and […]

In the second multibillion dollar acquisition this year involving a laboratory product and instrumentation company following the purchase of Millipore (see IBO 2/28/10), Thermo Fisher Scientific announced this month it will acquire Dionex for $2.1 billion in cash (see page 2), or approximately five times sales. This is Thermo’s largest acquisition since its 2006 purchase […]

Company Announcements Cisbio US agreed to distribute Multispan’s portfolio of cell lines in the US. Cisbio Bioassays announced in September that Promega’s HaloTag technology is available for use on its Tag-Lite platform. In October, Cisbio Bioassays partnered with Blue Sky BioProducts, the provider of TDA 2.0, a stable solution of lipid-based nanoparticles with nickel-chelating moieties. […]

Triple quadrupole LC/MS is one of the most broadly applicable of all MS techniques. One of the markets in which it is widely used is food safety. There are a range of food testing applications for which the technique is amenable, which will help drive solid growth in this market. No single analytical technique is […]

Company Announcements As part of its new out-licensing strategy, Life Technologies announced in September the finalization of cell line license agreements to provide rights to its Chinese hamster ovary cell lines for the production of recombinant protein used as therapeutic agents and vaccines. In October, Teledyne Tekmar partnered with Analytical Sciences Group, which will be […]